However, an update clinical study failed to show its survival benefit over chemotherapy in platinum-treated locally advanced or metastatic BC with PD-L1 expression ≥ 5%, further indicating the limited responses and effects of PD-L1/PD-1 checkpoint inhibitors and the need to develop novel strategies [7]. The gene discussed is CD274; the disease is breast cancer.